תבנית:תרופה/דיפרוג'נטה משחה - Diprogenta ointment
× ×ª×× × ×ª×¨×פ×
×××¨×©× 
| ×§×××¦× ×¤×¨××§×××××ת (ATC4) | |
|---|---|
| ×ר××× ×¤×¢×× (ATC5) | *Betamethasone AS DIPROPIONATE 0.5MG / 1G
|
| צ×רת ××ª× | TOPICAL |
| צ×רת ××× ×× | OINTMENT |
| ×ת×××× | Topical treatment of dermatosis complicated by secondary infection caused by organisms sensitive to Gentamicin
|
| ת×× ×ת:× ×ª×× × ×¡×/תר×פ×/××פר××'× ×× ×ש×× - Diprogenta ointment | |
| ×ת××ת ××× ×× | Posology and method of administration |
| ×ת××××ת × ×× | Contraindications |
| ת×פע×ת ××××× | Undesirable effects |
| ת××××ת ××× ×ª×¨×פת××ת | Interaction with other medicinal products and other forms of interaction |
| ש×××ש ×××ר××× ××× ×§× | Pregnancy and Lactation |
| פר××§××§×× ×××§× | Pharmacokinetic Properties |
| ×¢××× ×ר××¤× ××××ר×ת ××¢××× | |
| ×¢××× ×צר×× | *×¢××× ×צר×× |
|---|
| ער××× ×××××§×רפ××× | ער××× ×§×©×ר×× ×××××§×רפ××× |
|---|---|
| ××פר××'× ×× ×ש×× Â® ××××ר ××©×¨× ××ר×××ת |
| ××פ×ש ×××ר×× | - |
|---|---|
| ××××¢ ×רשת | - |
| ×©× ××¦×¨× | SCHERING-PLOUGH LABO. N.V , BELGIUM |
| ×©× ××¢× ×ר×ש×× | MERCK SHARP & DOHME ISRAEL LTD |
| ר×ש××× | ת×ר×× ××ש×: 08/1975. ר×ש××× ×ת×ר××: 03/2017 |
| ת×ר×× ×¢×××× ××ר×× | 14/08/18 |
××£ ×× × ×צר ×¢× ××× ××× ×××××ר ת×× ×ת ×¢× ×¤×¨×× ×תר×פ×.
- ××£ ×תר×פ×: ××פר××'× ×× ×ש×× - Diprogenta ointment
- ××ר××¡× ××× ×ת ×©× ×¤×¨×× ×תר×פ×: × ××ª× ×ער×× ×ת ××£ ×תר××¤× ××¢××. ×××××× ×××××¤× ×ת:
{{תר×פ×/××פר××'× ×× ×ש×× - Diprogenta ointment}}
×:
{{תר×פ×/××פר××'× ×× ×ש×× - Diprogenta ointment
| ×©× ×פר××ר=×¢×¨× ××ש (××רס ×ת ××¢×¨× ×©×××× ××××ר)
}}
השינוי האחרון נעשה בֹ־14 באוגוסט 2018 ב־15:47